Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
22 hedge funds and large institutions have $12.9M invested in Miromatrix Medical Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 21 → 22 (+1)
3% more capital invested
Capital invested by funds: $12.6M → $12.9M (+$348K)
0.07% more ownership
Funds ownership: 15.68% → 15.75% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFP
Sweet Financial Partners
Fairmont,
Minnesota
|
+$399K |
| 2 |
GS
Gagnon Securities
New York
|
+$162K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.4K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$51.8K |
| 5 |
LWAM
Legacy Wealth Asset Management
Woodbury,
Minnesota
|
+$51.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIMM
Stillwater Investment Management (Minnesota)
Stillwater,
Minnesota
|
-$357K |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
-$206K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$5.75K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 5 |
Morgan Stanley
New York
|
-$1.94K |
MIRO Hedge Fund Activity: Q2 2022 in Review
22 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q2 2022, worth a combined $12.9M — up 2.8% from $12.6M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MIRO positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Sweet Financial Partners, opening a new position worth an estimated $399K. The largest seller was Stillwater Investment Management (Minnesota), exiting entirely with an estimated $357K sold.
- 22 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q2 2022, up from 21 in Q1 2022.
- Funds reported $12.9M of Miromatrix Medical Inc. Common Stock stock for Q2 2022, up 2.8% quarter-over-quarter.
- 3 funds opened new Miromatrix Medical Inc. Common Stock positions in Q2 2022 and 2 closed out, a net change of +1 holder.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q2 2022 was Sweet Financial Partners, an estimated $399K added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q2 2022 was Stillwater Investment Management (Minnesota), an estimated $357K sold.
Based on aggregated 13F filings for Q2 2022.